Determination of cytosolic citrulline and nitrate as indicators of nitric oxide in bladder cancer: Possible association with basic fibroblast growth factor

Clinical Biochemistry

Volumn 32, Issue 8, 1999, Pages 635-638

  Khalifa, Ali ^a   Eissa, Sanaa ^a   Aziz, Ahmed ^b  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b THEODOR BILHARZ RESEARCH INSTITUTE   (Egypt)

Author keywords

Angiogenesis; Citrulline; Nitrate; Schistosomiasis

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CITRULLINE; NITRATE; NITRIC OXIDE;

ARTICLE; BLADDER CARCINOMA; CELL LEVEL; CONTROLLED STUDY; CYTOSOL; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCHISTOSOMIASIS;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CITRULLINE; CYTOSOL; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOENZYME TECHNIQUES; NITRATES; NITRIC OXIDE; REFERENCE VALUES; SCHISTOSOMIASIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 0033403422     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(99)00069-7     Document Type: Article

References (26)

1. Iarotski L.S., Davis S. The schistosomiasis problem in the world results of a WHO questionnaire survey . Bull WHO. 59:1981;115-127.
2. Tawfik H.N. Carcinoma of the urinary bladder associated with schistosomiais in Egypt the possible causal relationship . Miller RW, Ed. Unusual occurrences as clues to cancer etiology. 1989;197-209 Japan Science Society Press, Tokyo.
3. Chen M., Mott K. Progress in assessment of morbidity due to Schistosoma japonicum infection. Trop Dis Bull. 85:1988;2-56.
4. Hicks RM. Nitrosamines as possible etiologic agents in bilharzial bladder cancer: Banbury report 12. 455-69. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982.
5. Ohshima H, Calmels S, Pignatelli B, Vincent P, Bartsch H. N-Nitrosamine formation in urinary-tract infections. In: Bartsch H, O'Neil IK, Schulte-Herr-mann R, Eds. The relevance of N-nitroso compounds in human cancer: exposures and mechanism (IARC Sci. Publ. No 84). Pp. 384-90. Lyon, France: Intenational Agency for Research on Cancer, 1987.
6. Knowles R.G., Moncada S. Nitric oxide synthases in mammals (review). Biochem. 298:1994;249-258.
7. Gallo O., Masino E., Morbidelli D., Franchi A., Fini-Storchi I., Vergari W.A. The role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst. 90:1998;587-596.
8. Folkman J. Antiangiogenesis. DeVita VT Jr., Hellman S, Rosenberg SA, Eds, Biologic therapy of cancer. 1991;743-753 Lippincott, Philadelphia.
9. Weidner N., Semple J.P., Welch W.R. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med. 324:1991;1-8.
10. Folkman J., Klagsbrun M. Angiogenic factors. Science. 235:1987;442-447.
11. Folkman J., Shing Y. Angiogenesis. J Biol Chem. 267:1992;10931-10934.
12. Gonzalez A.M., Buscaglia M., Ong M. Distribution of basic fibroblast growth factor in the 18-day rat fetus localization in the basement membranes of diverse tissues . J Cell Biol. 110:1990;753-765.
13. Eissa S., Saada M.A., El-Sharkawy T. Flow cytometric cell cycle kinetics and quantitative measurement of c-erbB-2 and mutant p53 proteins in normal, hyperplastic, and malignant endometrial biopsies. Clin Biochem. 30:1997;209-214.
14. Bradford M.M. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Bioch. 72:1976;248-251.
15. Bories P.N., Bories C. Nitrate determination in biological fluids by an enzymatic one step assay with nitrate reductase. Clin Chem. 41:1995;904-907.
16. Kassim S. Determination of cytosolic nitrite and nitrate as indicators of nitric oxide level in ovarian cancer cells. Cancer Mol Biol. 4:1997;1051-1059.
17. Tapuhi Y., Chmidt E.S., Lindner W.L., Karger B.L. Dansylation of amino acids for high performance liquid chromatography analysis. Anal Biochem. 115:1981;123-129.
18. Badawi A.F. Molecular and genetic events in schistosomiasis-associated human bladder cancer role of oncogenes and tumor suppressor genes . Cancer Lett. 105:1996;123-138.
19. Middleton S.J., Shorthouse M., Hunter J.O. Increased nitric oxide synthesis in ulcerative colitis. Lancet. 341:1993;465-466.
20. Felley B.E. Role of nitric oxide in genotoxicity implication for carcinogenesis (review) . Cancer Metastasis. 17:1998;25-37.
21. Graziwicz M., Wink D.A., Laval F. Nitric oxide inhibits DNA ligase activity potential mechanisms for NO-mediated-DNA damage . Carcinogenesis. 17:1996;2501-2505.
22. Folkman J. Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med. 333:1995;1757-1763.
23. Boch T., Folkman J., Browder T., O'Reilly M.S. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature. 390:1997;404-407.
24. Bouck N. Tumor angiogenesis the role of oncogenes and tumor suppressor genes . Cancer Cells. 2:1990;179-185.
25. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86:1996;353-364.
26. Sasaki K., Hattori T., Fujisawa T., Takahashi K., Inou H., Takigawa M. Nitric oxide mediates interleukin-1 induced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes. J Biochem Tokyo. 123:1998;431-439.